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ABSTRACT
Objective: The objective of the study was to develop a new robust, sensitive, precise, accurate RP-HPLC analytical method and validate for simultaneous 
estimation of ribociclib and letrozole in solid dosage form (tablet).
Methods: The chromatographic separation was carried out on Waters, symmetry C18 (150 mm×4.6 mm with 3.5 µm), mobile phase used was a 
mixture of buffer and acetonitrile in the ratio of 80:20, with flow rate of 1ml/min and injection volume of 10 µL for the assay. The detection was done 
using PDA at 260 nm, with run time of 5 min. The retention time for the drugs ribociclib and letrozole was detected to be 2.648 min and 3.151 min, 
respectively. The method was validated according to ICH guidelines.
Results: The linearity of letrozole and ribociclib was observed to be in the range of 0.50–7.50 and 40.01–600.15, Correlation coefficient 
(r2) 0.999 and 0.9983, respectively. Accuracy for ribociclib and letrozole is carried out by repeatable concentrations of 50%, 100%, and 150. Validation 
factors of robustness and ruggedness were detected to be in limits.
Conclusion: The developed method was simple, rapid, and consistent; it can be used for the simultaneous estimation of ribociclib and letrozole tablet 
dosage form in routine analysis.
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INTRODUCTION
Chemically ribociclib is 7-cyclopentyl-N, N-dimethyl-2-{[5-
(1-piperazinyl)-2-pyridinyl] amino}-7H- pyrrolo[2,3-d]
pyrimidine- 6-carboxamide (Fig.1). Slight yellow to brown. It is freely 
soluble in dichloromethane; slightly soluble in ethanol; practically 
insoluble in water. Ribociclib holds cyclin-dependent kinase4 and 
6(CDk4/6) inhibitor2 helps to slow the progression of cancer [1-3]. 
The drug regulates cell cycle progression through phosphorylation of 
the retinoblastoma protein (pRb). The combination of ribociclib with 
anti-estrogen results in increased inhibition of tumor growth. 200 mg 
tablets of the drug are available for oral administration.
Chemically letrozole is 4,4-((1H-1,2,4-triazole-1-yl) methylene) 
dibenzo nitrile [4], orally active, nonsteroidal selective aromatase 
inhibitor, used for the treatment of postmenopausal women with breast 
cancer and being an antiestrogen [5]. Letrozole is soluble in organic 
solvents such as dimethyl sulfoxide (DMSO) and dimethyl formamide 
(DMF), which should be purged with an inert gas. The solubility of 
letrozole in these solvents is approximately 16 mg/ml, sparingly soluble 
in aqueous buffers [4]. It acts by irreversible binding to the heme of 
its cytochrome P450 unit. The action is distinct and does not reduce 
secretion of corticosteroids. Letrozole is considered as equally effective 
as ovariectomy in reducing uterine weight, by increasing serum LH and 
causing the retrogression of estrogen dependent tumors. As compared 
to ovariectomy treatment with letrozole will not cause in the level of 
serum FSH.
Survey of literature revealed that various RP-HPLC analytical methods 
were available for the determination of letrozole in combination with 
vilazodone/palbociclib and also for the determination of ribociclib 
individually or in combination with palbociclib [2]. Hence, an attempt 
was made to develop a simple, rapid, and validated method for the 




Acetonitrile (HPLC grade), Ortho Phosphoric Acid (HPLC grade), HPLC 
grade, Water (Milli Q or equivalent)
Instrumentation and chromatographic condition
Separation was carried out using the column Waters, Symmetry 
C18, 150 mm × 4.6 mm, 3.5 µm, with mobile phase Acetonitrile: Ortho 
Phosphoric Acid Buffer in ratio 20:80, was degassed and filtered by using 
0.45 µm membrane filter in a vacuum filter system. Separation was carried 
out at room temperature by injecting 10 µl with flow rate 1.0 ml/min. The 
analytes were quantified with PDA detector at 260 nm.
Preparation of solutions
Buffer 1 ml of O-phosphoric acid buffer dissolved in 1 L of HPLC water.
Diluent mobile phase used as diluent.
Standard solution
400 mg of ribociclib and 5 mg of letrozole working standards were 
taken into a 100 ml volumetric flask, 70 ml of diluents was added and 
sonicated for 15 min to dissolve the contents, the final volume was 
made with diluent. 5 ml of above solution was pipetted out and diluted 
to 50 ml with diluent.
Preparation of sample solution
Average weight of five tablet taken, then three tablets were powered 
into power form, 500 mg of powder was taken in a 100 ml volumetric 
flask, 70 ml of diluent was added and sonicated for 30 min to dissolve 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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the contents completely. 5 ml of above solution was pipette out and 
diluted to 50 ml with diluent.
Procedure for assay
Six replicates of standard and sample were analyzed. 10 µl of blank, 
standard solution and sample solution was injected into the HPLC 
system. From the peak area of the chromatogram, the percentage purity 
of the sample was calculated.
Method validation
The optimized chromatographic condition is applied for quantitative 
determination and the method was validated by considering some 
parameters linearity, precision, accuracy (% recovery), robustness, 
system precision, method precision, and ruggedness [5,6].
Specificity
The specificity of an analytical method is its ability to quantify with precision 
and especially the analyte of interest in the presence of other components 
that are likely to be present in the sample. The blank, standard, sample, and 
placebo solutions were injected to check the interference.
Linearity
It is the ability of the method to produce the test results which are 
directly proportional to the concentration of analyte in the sample 
solution. Six concentrations for the drugs letrozole and ribociclib at 
0.50, 1.25, 2.50, 5, 6.25, and 7.50 µg/mL and 40.01, 100.03, 200.05, 
400.10, 500.13, and 600.15 µg/mL, respectively, were prepared from 
the standard solution and 10µl of each was injected.
Accuracy
The accuracy of an analytical method is the proximity of the test 
results derived by that method to the true value. This is sometimes 
termed trueness. It is proposed that accuracy should be determined 
using not less than nine determinations over a minimum of the 
three concentration levels, covering the specified range (three 
concentrations/three replicates each of total analytical procedures). 
Accuracy was studied using the standard addition method. For letrozole 
recovery studies, 2.5 mg of standard was added for 50%, 5 mg was added 
for 100%, and  7.5 mg was added for 150%, for ribociclib,  200 mg was 
added for 50%, 400 mg was added for 100%, and 600 mg for 150% 
was added to the previously prepared test solutions.
Table 1: Working standard for letrozole
Std. Name Letrozole % Potency 100.0
STD wt. (mg) 5.00
Dilutions Wt taken in mg into 100 mL Concentration 
(ppm)
50
5 mL 50 mL 5
1 mL 1 mL 5
Table 2: Working standard for ribociclib
Std. Name Ribociclib % Potency 100.0
STD wt. (mg) 400.10
Dilutions Wt taken in mg into 100 mL Concentration 
(ppm)
4001
5 mL 50 mL 400.1
1 mL 1 mL 400.1
Fig. 2: Optimized chromatogram. Retention time of ribociclib is about 2.648 min. Retention time of letrozole is about 3.151 min
Fig. 4: Linear plot for letrozole
Fig. 3: Linear plot for ribociclib
Fig. 1: (a) Ribociclib, (b) Letrozole
a b
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Precision
The precision of an analytical method is the degree of agreement 
among individual test results when the method is recurrent to multiple 
samplings of samples that are not homogenous in nature.
System precision
Six replicates of standard solution of both the drug were analyzed by 
the same analyst, on the same equipment on the same day. Area of the 
peak and % RSD were calculated.
Method precision
Six different standard solutions for both the drug were prepared from 
homogenous sample solution and were analyzed by the same analyst, 
on the same equipment on the same day. The assay results and % RSD 
were calculated.
Robustness
The robustness determines the influence of small but steady variation 
in the chromatographic conditions. The robustness of the method was 
Table 3: Linearity for ribociclib and letrozole
Ribociclib Letrozole
mL of lin stock Vol. made up to μg/mL Area count mL of Lin stock Vol made upto μg/mL Area count
0 0 0.00 0 0 0 0.00 0
0.5 50 40.01 303014 0.5 50 0.50 214633
1.25 50 100.03 739150 1.25 50 1.25 464156
2.5 50 200.05 1461298 2.5 50 2.50 832584
5 50 400.10 2880851 5 50 5.00 1726321
6.25 50 500.13 3596077 6.25 50 6.25 2062896
7.5 50 600.15 4089562 7.5 50 7.50 2524821
Correl Coeff. 0.99915 Correl Coeff. 0.99953 0.99953 0.99953
Slope 6942.87 Slope 331753.49 331753.49 331753.49
Intercept 41695.91 Intercept 27868.66 27868.66 27868.66
Linear regression analysis curves (n=6)
Table 4: For letrozole
Letrozole











50% accuracy 2.5 2.50 152463 152463 2.47 98.8 Mean 99.1
2.5 2.50 154284 154284 2.5 100.0 SD 0.83
2.5 2.50 151312 151312 2.46 98.4 %RSD 0.840
100% accuracy 5 5.00 308443 308443 5.01 100.2 Mean 99.9
5 5.00 307618 307618 4.99 99.8 SD 0.23
5 5.00 307284 307284 4.99 99.8 %RSD 0.230
150% accuracy 7.5 7.50 462031 462031 7.5 100.0 Mean 99.8
7.5 7.50 464570 464570 7.54 100.5 SD 0.89




*SD: Standard deviation, *% RSD: % relative standard deviation
Table 5: For ribociclib
Ribociclib
Batch no Area Counts Potency (As is basis) 100.0




Mean Amount % Recovery
Injection Area Counts Recovered (mg)
50% accuracy 200 200.00 1360582 1360582 197.53 98.8 Mean 99.1
200 200.00 1364716 1364716 198.13 99.1 SD 0.28
200 200.00 1368218 1368218 198.64 99.3 %RSD 0.280
100% accuracy 400 400.00 2744501 2744501 398.44 99.6 Mean 99.4
400 400.00 2746991 2746991 398.8 99.7 SD 0.50
400 400.00 2721988 2721988 395.17 98.8 %RSD 0.500
150% accuracy 600 600.00 4071373 4071373 591.08 98.5 Mean 98.6
600 600.00 4072024 4072024 591.17 98.5 SD 0.22




*SD: Standard deviation, *% RSD: % relative standard deviation
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Table 6: For working standards
Working standard Letrozole Dilutions ppm
Wt. taken (mg) 5 Taken in to 100 ml 50.0
B. No 5 ml to 50 ml 5.0
% Potency 100.0 w/w 
(as is 
basis)
1 ml to 1 ml 5.0
Working standard Ribociclib Dilutions ppm
Wt. taken (mg) 400.1 Taken in to 100 ml 4001.0
B. No 5 ml to 50 ml 400.1
% Potency 100.0 w/w 
(as is 
basis)
1 ml to 1 ml 400.10
Table 7: For system precision
Ribociclib Letrozole










% RSD 0.153 0.269
*SD: Standard deviation, *% RSD: % relative standard deviation
determined by changing the flow rate (0.9 and 1.1mLmin_1) of the 
mobile phase, pH of ortho phosphate buffer, ratio of composition of the 
mobile phase and wavelength.
Limit of detection and limit of quantitation
Limit of detection is the lowest amount of sample detected by an analytical 
procedure but not quantified exactly. Limit of quantitation is the lowest 
amount of sample that can be quantified by an analytical procedure.
As per ICH guidelines, in the simultaneous analytical method development 
study, limit of detection and limit of quantitation were based on the 
standard deviation of the response and slopes using signal-to-noise ratio.
RESULTS AND DISCUSSION
Several trials have been performed for the development of the method 
by changing the column, flow rate, mobile phase ratio, and wavelength.




Mobile phase ratio Acetonitrile and ortho phosphoric acid (20:80)
Column Waters, symmetry C18, 150 mm×4.6 mm, 3.5 
µm
Flow rate 1.0 ml/min
Wavelength 260 nm
Injection Volume 10 µL
Elution mode Isocratic




Table 9: Method precision for letrozole
Letrozole
Standard area counts Sample area counts
Injection Area Brack. Std. Sample weight (mg) Area counts injection Mean area counts % label claim
1 309393 304867 500.2 305295 305295 99.0
2 308271 500.4 305997 305997 99.2
3 307449 500.2 309917 309917 100.5
4 308183 500.1 307131 307131 99.6
5 307998 500.4 303496 303496 98.4
Mean 308259 307694 500.3 308831 308831 100.1
SD 709.95 1523.35 Mean 99.5
% RSD 0.23 0.495 SD 0.763
% RSD 0.77
*SD: Standard deviation, *% RSD: % relative standard deviation
Table 8: Method precision for ribociclib
Ribociclib
Standard area counts Sample area counts








1 2760981 2748621 500.2 2747629 2747629 99.7
2 2757098 500.4 2711616 2711616 98.3
3 2751049 500.2 2716991 2716991 98.6
4 2752301 500.1 2730071 2730071 99.1
5 2760385 500.4 2754107 2754107 99.9
6 2753672 500.3 2773887 2773887 100.6
Mean 2755914 2754872 Mean 99.4
SD 4214.61 4733.01 SD 0.862
% RSD 0.153 0.172 % RSD 0.87
*SD: Standard deviation, *% RSD: % relative standard deviation
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Validation of proposed method
Linearity
Linear correlation was prevailed between peak area versus 
concentration of letrozole and ribociclib. Calibration curves were 
linear in the concentration range from 0.50 µg/mL and 7.50 µg/mL for 
letrozole and 40.01 µg/mL and 600.15 µg/mL for ribociclib. Linearity 
of the calibration curves was validated from the value of correlation 
coefficients of the regression analysis. The value of r2 was 0.99953 
for letrozole and 0.9983 for ribociclib. The results of the linearity 
experiment are listed in Tables 1-3 and the calibration plot is given in 
Figs. 3 and 4 for ribociclib and letrozole, respectively.
Accuracy
The experiments were performed in accordance to standard addition 
method. The percentage recovery and % RSD were calculated for 
both ribociclib and letrozole. The % RSD was found to be within limit 
(Tables 4 and 5).
Precision
System precision: Six injections of standard solutions of both the drugs 
were injected. The results are listed in the Tables 6 and 7.
Method precision
Method precision determined with developed method (n=6).
The precision of the method was given in the Tables 8-11.
Table 13: For ribociclib






 Mean %label 
claim of sample
SD %label claim 
of sample
RSD %label claim 
of sample
Flow plus 2528147 16839.14 0.666 99.9 0.586 0.59
Flow minus 3331018 18882.69 0.567 100.2 0.503 0.5
Org plus 2769764 13196.04 0.476 99.7 0.929 0.93
Org minus 2909548 9672.9 0.332 100.3 0.306 0.31
pH plus 2532149 14183.74 0.56 100.2 0.208 0.21
pH minus 3348280 24029.87 0.718 100 0.2 0.2
Wave plus 2649954 4215.42 0.159 99.9 0.404 0.4
Wave minus 3328400 3245 0.097 99.9 0.058 0.06













Flow plus 288126 5001.4 1.736 100.7 0.058 0.06
Flow minus 371291 4037.32 1.08 99.9 0.3 0.3
Org plus 313139 3702.98 1.183 99.5 0.265 0.27
Org minus 344854 2773.86 0.804 99.6 0.361 0.36
pH plus 284983 2683.53 0.926 99.4 0.681 0.69
pH minus 346080 3405.23 0.984 99.8 0.954 0.96
Wave plus 296935 1617.65 0.545 100.2 0.577 0.58
Wave minus 325860 673.78 0.207 99.6 0.889 0.89
Table 11: Limit of quantitation
Sample name Sample concentration Retention Time Area (μV*sec) % area USP tailing s/n USP plate count USP resolution
Ribociclib 4.005 2.629 302070 90.69 1.09 27 3095
Letrozole 0.05 3.131 31002 9.31 1.10 22 3980 2.58
Table 10: Limit of detection (LOD)
Sample name Sample concentration Retention Time Area (μV*sec) % Area USP tailing s/n USP plate count USP resolution
Ribociclib 0.4001 2.639 17081 71.29 1.09 7 3179
Letrozole 0.005 3.140 2630 28.71 1.15 5 3839 2.52
Limit of detection (LOD) and limit of quantitation (LOQ)
The limit of detection for letrozole and ribociclib was found to be 0.005 
and 0.4001 µg/mL, while the limit of quantitation for letrozole and 
ribociclib was found to be 0.05 and 4.005 µg/mL, respectively.
Robustness
The intend changes in the method do not have more impact in the 
peak tailing, theoretical plates, and the percent assay of letrozole and 
ribociclib. It has been performed by changing the composition of the 
mobile phase, flow rate, wave, and pH of buffer (Tables 12 and 13).
CONCLUSION
The suggested RP-HPLC method was rapid, more precise, robust, and 
sensitive. This RP-HPLC method accommodates the utilization of the 
economically and simply available mobile phase and PDA detector. The 
validated method can be used for the routine analysis of both the drugs 
from bulk and different formulations and will help in therapeutic drug 
monitoring (TDM) and bioavailability studies.
ACKNOWLEDGMENT
The authors would like to thank the management of Avanthi Institute 
of Pharmaceutical Science, Visakhapatnam for providing the necessary 
facilities and funding to carry out of this research work. The authors are 
grateful to ICON labs, Hyderabad for providing a gift sample of the drug 
and other facilities too.
134
Asian J Pharm Clin Res, Vol 14, Issue 11, 2021, 129-134




1. Kala A, Patel YT, Davis A, Stewart CF. Development and validation 
of LC-MS/MS methods for the measurement of ribociclib, a CDK4/6 
inhibitor, in mouse plasma and Ringer’s solution and its application to 
a cerebral microdialysis study. J Chromatogr B Analyt Technol Biomed 
Life Sci 2017;1057:110-7.
2. Sreelakshmi M, Sasidhar RL, Raviteja B. Simultaneous estimation 
of ribociclib and palbociclib in bulk samples by reverse phase 
high performance liquid chromatography. Int J Pharm Biol Sci 
2019;9:413-21.
3. Bao X, Wu J, Sanai N, Li J. Determination of total and unbound 
ribociclib in human plasma and brain tumor tissues using liquid 
chromatography coupled with tandem mass spectrometry. J Pharm 
Biomed Anal 2019;166:197-204.
4. Kaplan C, Ünal S. A Validated Method without Derivatization 
for the Determination of Letrozole by High Performance Liquid 
Chromatography-Fluorimetric Method for Pharmaceutical Preparation. 
Turkey: Istanbul University Press; 2018. p. 38-42.
5. Mondal N, Pal TK, Ghosal SK. Development and validation of 
RP-HPLC method to determine letrozole in different pharmaceutical 
formulations and its application to studies of drug release from 
nanoparticles. Acta Pol Pharm 2009;66:11-7.
6. Dange Y, Bhinge S, Salunkhe V. Optimization and validation of 
RP-HPLC method for simultaneous estimation of palbociclib and 
letrozole. Toxicol Mech Methods 2018;28:187-94.
